of Best Children’s Hospitals. CHLA is the top-ranked children’s hospital in California and the Pacific U.S. region for 2024-25. Children’s Hospital Los Angeles embraces its mission to create hope and build healthier futures. Children’s Hospital Los...
for regulatory approval of lecanemab in 16 other countries and regions, including the European Union. In November 2024, the treatment received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending approval. A...
with advanced or refractory cancers expressing DLL3. A Phase I clinical trial of PT217 is also ongoing in China (CTR20242720). Earlier this year, Phanes entered into a clinical supply agreement with Roche to study PT217 in combination with Roche's...
"LEQEMBI®" has been launched in South Korea. LEQEMBI received the Ministry of Food and Drug Safety (MFDS) approval in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer's disease (AD) or mild AD dementia (early...
NS Pharma, Inc. announced a change of leadership within its Commercial division. Effective September 9, 2024, Donald Foy – who had previously served as national sales director – was appointed to the role of vice president, Commercial. Jennifer...
is pleased to announce the “International conference on Pharmaceutics and Drug Delivery Systems” to be held on Nov 26-27, 2024 at Dubai, UAE. Genvio Group is pleased to announce the “International conference on Pharmaceutics and Drug Delivery...
often nonfunctional protein and effectively causing a loss of function. Their study appeared online on November 01, 2024 in the journal Experimental & Molecular Medicine. Highlighting the significance of this achievement, senior author Prof. Lee...
International Conference on Neuroscience and Neurology” in Amsterdam, Netherlands, on November 18-20, 2024. International Conference on Neuroscience and Neurology” in Amsterdam, Netherlands, on November 18-20, 2024. This Neurology conference and...
compliant marketing. Axonal.AI was founded by Larry Mickelberg, who was named earlier this year as one of MM+M Magazine’s 2024 Top Healthcare Marketing Influencers. With over 20 years of leadership experience at leading management consultancies and...
Aadi Bioscience, Inc. announced financial results for the third quarter ended September 30, 2024, and provided recent corporate progress. "The third quarter saw strong sales growth for FYARRO, backed by continued account momentum, increased demand...
to discovering and developing innovative medicines for patients, reported financial results for the third quarter of 2024 and provided business updates. HanAll ended the third quarter with total revenue of 36.8 billion KRW, reflecting an 11.7%...
2nd International Conference on Biotechnology and Bioengineering, a Hybrid Event scheduled from October 24-25, 2024, Paris, France. We cordially invite competitors from all corners of the globe to showcase their expertise, talents, and research in...
NanoMedicine 2024 will cover the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Participants will get a complete overview on the state of the art in these fields and on the research carried out and the...
3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the clinical trial industry. 3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the...
Prostate cancer is the second-leading causes of cancer death in American men. The American Cancer Institute estimates in 2024 there will be 299,310 new cases of prostate cancer in the US and around 35,250 deaths from the disease[2]. About Clarity...
16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in Tokyo, Japan. 16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in...
Eisai Saudi Arabia was established in April 2024 in order to build an in-house sales system. Japan-based Eisai Co. has announced that fully-fledged operations and business activities have begun at Eisai Pharmaceuticals Single Person Limited...
in Patients with Prostate Cancer: A Comprehensive Systematic Review and Meta analysis." Journal of Nuclear Medicine (2024). About Radiohybrid Prostate‐Specific Membrane Antigen (rhPSMA): rhPSMA compounds are referred to as radiohybrid ("rh"), as...
With the global clinical trial management system market projected to rise to $2.72 billion by 2028, the pharma industry is witnessing a significant shift towards embracing technology-driven solutions to enhance efficiency, streamline processes,...
scientific challenges, enabling researchers to make meaningful advances in their fields. Promega invites attendees of SFN 2024 to Booth #1316 to experience live demonstrations of the Glomax® Galaxy, showcasing its potential to transform research....
